Here we report, for the first time, that luteolin has a promotion on apoptosis and autophagy by the SGK1-FOXO3a-BNIP3 pathway in TNBC, which provides novel insights into the exploring of anti-cancer efficacy of luteolin and implies that SGK1 might provide a therapeutic target for TNBC. Here, SGK1 is linked to cancer.